Where innovative Medical Go-To-Market Success is the rule! 

Want to Learn or See More? Click here

Synergistic Marketing, founded in 1990 by Mark Lutvak, is a successful, growing and profitable sales and marketing contracting firm and consultancy. We are dedicated to serving Small Emerging businesses that own or possess Medical Technology or Medical Device IP. We support our clients with a go-to-market strategy that takes advantage of our extensive network of medical industry companies as well as our extensive list of contacts who are our Corporate Partners.

Want to Learn or See More? Click here


Medical Technology and Device News Title

  • March 2, 2015:

    Cardinal Health Inc. agreed to buy Johnson & Johnson’s Cordis business for $1.94 billion in cash, bulking up the medical distributor’s device-making capabilities. Biegelsen, analyst at Wells Fargo in New York indicated the deal is not without risks as there are powerful competitors like Abbott Laboratories.
    The purchase, financed with a combination of $1 billion in new senior unsecured notes and existing cash, will also result in cost savings of more than $100 million annually by the end of fiscal 2018. Cardinal Health expects the proposed deal to add more than 20 cents per share to its fiscal 2017 adjusted earnings. “This is a significant step forward in our cardiovascular strategy,” George Barrett, Cardinal’s chief executive, said in a statement Monday... Full Story

  • February 17, 2015:

    The Office of the National Coordinator for Health Information Technology (ONC) is asking for public feedback on a draft plan for the seamless sharing of electronic health records (EHRs).
    Released Jan. 30, Connecting Health and Care for the Nation: A Shared Nationwide Interoperability Roadmap(PDF) highlights actions healthcare information technology (IT) stakeholders must take to achieve the ONC’s vision of interoperability detailed in a concept paper unveiled in June 2014. Actions listed in the report, which is open to comment until April 3, are designed to give the majority of individuals and providers the ability to use a common set of electronic clinical information by the end of 2017. In addition, it describes four actions to achieve near-term wins.... Full Story

  • February 12, 2015:

    A study in the Feb. 17 issue of the Journal of the American College of Cardiology found patients with lesions on post-intervention magnetic resonance imaging were more than twice as likely to have a stroke or transit ischemic attack (TIA) in the five years that followed.
    Henrik Gensicke, MD, from the University Hospital Basel in Switzerland, and colleagues focused on the data on the 124 patients from the International Carotid Artery Stenting Study who underwent CAS over the course of the parent study. They found new ischemic lesions through DWI in 62 patients. The probability of having a stroke or TIA at one year for patients with lesions was 15.1 percent, as opposed to 3.2 percent for those without. The highest risk of stroke or TIA occurred within the first six months following treatment. Full Story

  • February 12, 2015:

    For the first time, researchers have reversed some of the symptoms of Alzheimer’s disease in mice using magnetic resonance (MR) imaging-guided focused ultrasound.
    In this study, a medical physicist at Sunnybrook Research Institute in Toronto, and his collaborators studied the effects of using MR imaging-guided focused ultrasound on mice with the TgCRND8 genetic variant which display symptoms similar to Alzheimer’s such as memory impairment and learning reversal. Thus, transgenic mice are used as an animal model for Alzheimer’s disease. MR imaging-guided focused ultrasound has been shown to temporarily open the blood-brain barrier (BBB), which allows for more effective delivery of drugs to the brain. They found the treatment led to improvements in cognition and spatial learning in the subject mice.Full Story

  • February 10, 2015:

    A team of Purdue University researchers has been awarded a $1 million W.M. Keck Foundation grant to develop a new way to perform in-vivo spectroscopy  using a pulsing laser light to determine the precise chemical content of tissues in living organisms.
    Dr. Cheng,  professor at Purdue's Weldon School of Biomedical Engineering and Department of Chemistry says "This work is potentially very important because if we know the chemical content of tissue we can achieve early disease detection not possible with current medical imaging technologies”. Full Story

  • February 8, 2015:

    Hydrogels are materials that are commonly used in everyday objects such as contact lenses or diapers, in order to control humidity. Eduardo Mendizábal Mijares, professor at the Department of Chemistry, in the University of Guadalajara, said "we used nano-hydrogels loaded with drugs and injected them into the patient. With the characteristic that while passing through the bloodstream the drug is not detected nor attacked by the immune system, this due to their physical and chemical properties which make them compatible with the body". This technique allows the drugs to be transported directly to cancer cells where it can be released without damaging other parts of the body...Full Story

  • February 4, 2015:

    MedShape, Inc. has received U.S. Food and Drug Administration 510(k) clearance for 3-D printing of medical grade titanium alloy (Ti-6AL-4V) that allows for the fabrication of devices with complex and/or customizable geometries, such as the Bunion Correction System, a new approach to surgically correct hallux valgus deformities that preserves and protects the native bone anatomy. The FastForward Bone Tether Plate represents a breakthrough in bunion correction by allowing suture tape to be securely and safely wrapped around the second metatarsal eliminating the need to drill through the bone, thereby greatly improving the long term prognosis.Full Story